Search results for: Health Care Systems
Filter search results
2021 OHE Annual Report to the Charity Commission
1 December 2022
…health economics and health care policy; and using health economics methods to produce evidence-based health policy and health care management that contributes to a more efficient and effective health care…
Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
1 February 2015
Stated preference studies are increasingly being used to understand people’s views about the relative importance of different criteria for making health care priority setting decisions. Stated preference studies are increasingly…
Data Governance Arrangements for Real-world Evidence in Japan
12 September 2019
…limited to, administrative claims data for healthcare services, national health check-up data, the Diagnosis Procedure Combination (DPC) data, and Electronic Medical Records. In Japan, the legal framework for using personal…
Prospects in Health
1 June 1971
In advanced countries, the majority of medical care is no longer concerned with prevention of death. Better social conditions, modern scientific medicine and in particular immunisation and chemotherapy have removed…
OHE’s submission to Belgium’s Committee on Health and Equal Opportunities argues value-based pricing delivers a ‘triple-win’
18 December 2024
…the pricing of medicines or pharmaceutical specialities to be based on transparent and objective criteria. Professor Cookson’s response proposes a value-based approach to pricing, which would allow: • Healthcare systems…
OHE Lunchtime Seminar on 29 April 2015: Do Financial Incentives Trump Clinical Guidance? Hip Replacement in England and Scotland
24 March 2015
…are focused on performance measurement, international comparisons of health systems and performance based payment systems. Professor Alistair McGuire is a Professor in Health Economics at LSE Health and Social…
One Europe, one assessment? Unpacking the European Joint Clinical Assessment
28 May 2026
…requirements varying substantially due to differences in healthcare systems, institutional frameworks, evaluation criteria, and societal preferences. Against this fragmented landscape, the JCA aims to: Reduce duplication in HTA processes across EU member…
Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges
6 February 2023
…top of the initial payment for manufacturing and distribution of the product. Being optional, this alternative, flexible, instrument would delink prices, allowing health systems and payers to initially purchase new…
Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK
14 March 2017
…technology assessment (HTA) decisions are implemented by national health systems. Our analysis found that since the implementation of the OMP Regulation, 143 OMPs have obtained marketing authorisation in the EU. These…